Key Highlights

  • VCI Global (NASDAQ:VCIG) dropped 31.37% to USD 5.60 after a 1-for-18 reverse split.
  • Huachen AI Parking Management Technology (NASDAQ:HCAI) fell 8.97% to USD 2.13 following a 1-for-20 split.
  • Cellyan Biotechnology (NASDAQ:HKPD) rose 9.29% to USD 2.00, with a January 11, 2027 Nasdaq deadline ahead.
  • Dragonfly Energy (NASDAQ:DFLI) climbed 9.45% to USD 1.99 after a 1-for-8 split.
  • Sangrix (NASDAQ:SGRX) gained 9.08% to USD 0.8050, with 128 GPUs expected this week.

VCI Global (NASDAQ:VCIG) (down USD 2.56, 31.37%): Steep Decline Following a 1-for-18 Split

In pre-market trading on November 3, 2026, VCI Global (NASDAQ:VCIG) fell 31.37% to USD 5.60. Its 1-for-18 reverse split became effective at 12:01 a.m. Eastern Time on November 2, 2026, and no separate company announcement dated November 2 or November 3, 2026 was identified.

Shares outstanding were expected to drop from about 9,639,594 to about 535,533. The company said the split is meant to satisfy the Nasdaq minimum bid price and to set it up for a potential "landmark institutional transaction," which it did not describe. It has consolidated before, with earlier splits of 1-for-60 and 1-for-15. With so few shares left, pre-market quotes may be unreliable.

Huachen AI Parking Management Technology (NASDAQ:HCAI) (down USD 0.2099, 8.97%): Surrendering an Earlier Gain

After a pre-market jump on November 2, 2026, Huachen AI Parking Management Technology (NASDAQ:HCAI) slipped 8.97% to USD 2.13 in pre-market trading on November 3, 2026. No company announcement dated November 2 or November 3, 2026 was identified.

A 1-for-20 split took effect on October 23, 2026, cutting Class A shares from 10,379,942 to approximately 518,997 (company figure). It was the second split of 2026. First half 2026 Revenue was USD 2.47 million and Net Income was USD 51,273, down 96%. Cash was not identified in the sources reviewed. This Penny Stock brings volatility, thin Liquidity and dilution risk.

Cellyan Biotechnology (NASDAQ:HKPD) (up USD 0.1700, 9.29%): A Rebound Weeks After the Split

Cellyan Biotechnology (NASDAQ:HKPD) gained 9.29% to USD 2.00 in pre-market trading on November 3, 2026, from an implied Monday close of about USD 1.83 (calculated). No company announcement dated October 30 to November 3, 2026 was identified.

The 1-for-20 split became effective on October 26, 2026. Nasdaq gave the company until January 11, 2027 to regain a closing bid of at least USD 1.00, and the company said there is no assurance it will. Fiscal 2025 revenue was USD 20.3 million, according to market data. A shelf registration covering up to USD 200 million of securities could bring dilution if used. It is a penny stock.

Dragonfly Energy (NASDAQ:DFLI) (up USD 0.1718, 9.45%): Battery Maker Recovers After a Reset

Dragonfly Energy (NASDAQ:DFLI) climbed 9.45% to USD 1.99 in pre-market trading on November 3, 2026, from an implied Monday close of about USD 1.82 (calculated). No company announcement dated November 2 or November 3, 2026 was identified.

A 1-for-8 split took effect on October 12, 2026 to address Nasdaq Listing Rule 5550(a)(2). Second quarter 2026 net sales were USD 13.2 million, and management said softness in recreational vehicles persists. Full year 2025 revenue was USD 58.63 million against a net loss of USD 70.81 million, according to market data. Trading below USD 5, this penny stock carries dilution risk.

Sangrix (NASDAQ:SGRX) (up USD 0.0670, 9.08%): GPU Arrival Window and a Split on the Calendar

Sangrix (NASDAQ:SGRX) gained 9.08% to USD 0.8050 in pre-market trading on November 3, 2026. No company announcement dated November 2 or November 3, 2026 was identified. Market data showed a rise of roughly 83.5% on October 30, 2026.

A company release dated October 16, 2026 said 128 Blackwell B300 GPUs are expected in the week of November 3, 2026, depending on the manufacturer's logistics schedule. A filing summary listed a 1-for-10 split as scheduled for November 13, 2026, and noteholders converted Debt at USD 1.63 per share. This penny stock has a small float, and further dilution is possible.

The Common Thread

These five stocks follow a pattern: companies consolidating shares to meet Nasdaq's USD 1 minimum bid price, then trading on very small share counts, where large pre-market moves can happen without news. Sangrix, with its pending GPU delivery, and Cellyan, with its January 11, 2027 deadline, have the clearest dates to track. Readers should also watch Nasdaq compliance letters, share issuance and regular session Volume to see whether pre-market moves last.